once-weekly semaglutide in adults with overweight or obesity
It has been proposed for treatment of PD due to an in vitro study showing it prevents tunica albuginea fibroblast proliferation, attenuates TGF-B mediated deposition of collagen, reduces deposition of elastin, and increases fibrinolytic activity (31-33)
Its active ingredient is semaglutide the same molecule found in Wegovy (FDA-approved for chronic weight management) and Rybelsus (oral daily tablet for diabetes)
Peak semaglutide levels in your bloodstream occur about 13 days after your injection, depending on your body composition and metabolism
(Official Site)
Martiny K, Refsgaard E, Lund V, Lunde M, Thougaard B, Lindberg L, Bech P